Drug Shortage Report for SANDOZ VENLAFAXINE XR
Report ID | 83301 |
Drug Identification Number | 02310333 |
Brand name | SANDOZ VENLAFAXINE XR |
Common or Proper name | VENLAFAXINE XR |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 150.0MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 250 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-05-03 |
Estimated end date | 2019-12-20 |
Actual end date | 2020-01-16 |
Shortage status | Resolved |
Updated date | 2020-01-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-01-22 | French | Compare |
v9 | 2020-01-22 | English | Compare |
v8 | 2019-10-15 | French | Compare |
v7 | 2019-10-15 | English | Compare |
v6 | 2019-09-25 | French | Compare |
v5 | 2019-09-25 | English | Compare |
v4 | 2019-06-12 | French | Compare |
v3 | 2019-06-12 | English | Compare |
v2 | 2019-05-07 | French | Compare |
v1 | 2019-05-07 | English | Compare |
Showing 1 to 10 of 10